06/02/2023 /
The Medtronic Registry for Epilepsy (MORE) aims to assess ANT DBS therapy’s safety and longer-term effectiveness in routine clinical practice.
06/01/2023 /
Epilepsy Awareness Night with the Chicago White Sox, our mental health webinar, and more in this Update.
05/31/2023 /
Early identification of children who will develop epilepsy after a CFS is essential to future management and counseling for parents/caregivers
05/30/2023 /
The prevalence of seizures roughly doubles between the ages of 50 and 80 years. More than 95% of patients with epilepsy are treated with ASMs as they are effective at preventing recurrent seizures; however, older adults may be vulnerable to the side effects of ASMs.
05/26/2023 /
Up to 1 in 4 people with hard-to-treat epilepsy, including those with Dravet syndrome, were found to stop taking Epidiolex (cannabidiol) shortly after starting treatment, primarily due to side effects or a lack of efficacy, according to a real-world study.
05/25/2023 /
A new study finds that some infants who die of SIDS have abnormalities in a particular brain receptor that may be involved in helping them gasp for air.
05/24/2023 /
Findings suggest that diagnostic delays are common for this rare form of the disease, so researchers urge clinicians to consider it as a potential diagnosis for patients who develop vision problems in childhood and seizures in adolescence or adulthood.
05/23/2023 /
Effective long-term medical treatment with cenobamate may reduce excess mortality associated with epilepsy.
05/21/2023 /
Future research needs to investigate the therapeutic effects of CBD and AEs in the presence of various dosages of other antiepileptic dugs in order to achieve a safe and effective dose for treatment-resistant patients with epilepsy.
